Parallax Volatility Advisers’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,600
Closed -$5.77M 1610
2024
Q4
$5.77M Buy
50,600
+15,600
+45% +$1.78M 0.01% 777
2024
Q3
$4.16M Hold
35,000
0.01% 864
2024
Q2
$2.81M Sell
35,000
-24,600
-41% -$2.25M 0.01% 911
2024
Q1
$5.5M Sell
59,600
-50,000
-46% -$4.79M 0.01% 705
2023
Q4
$11.6M Sell
109,600
-25,400
-19% -$2.56M 0.02% 544
2023
Q3
$14.7M Sell
135,000
-45,000
-25% -$4.98M 0.03% 419
2023
Q2
$19.4M Buy
180,000
+171,500
+2,018% +$19.3M 0.04% 352
2023
Q1
$1.06M Sell
8,500
-47,000
-85% -$6.45M ﹤0.01% 1478
2022
Q4
$8.34M Sell
55,500
-1,400
-2% -$215K 0.01% 840
2022
Q3
$7.67M Buy
56,900
+1,400
+3% +$214K 0.01% 849
2022
Q2
$8.28M Sell
55,500
-164,900
-75% -$25.2M 0.01% 794
2022
Q1
$37.6M Buy
+220,400
New +$37M 0.02% 332

Other funds holding BNTX

Parallax Volatility Advisers's BNTX Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 2,447 shares — an estimated $261K sold.

Parallax Volatility Advisers first reported a position in BNTX in Q1 2022 and held it in 14 quarters. The position peaked at $11.9M in Q1 2022. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,447 BioNTech shares in Q3 2025, an estimated $261K.
  • Parallax Volatility Advisers first reported a position in BioNTech in Q1 2022 and held it in 14 quarters.
  • Parallax Volatility Advisers's BioNTech position peaked at $11.9M in Q1 2022.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.